LUCINACTANT
UNII 5BSH2G9BH8

Substance Identification & Data

This profile provides standardized clinical and technical data for Lucinactant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5BSH2G9BH8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 825600-90-6 and the RxNorm Concept ID (RxCUI) 1293254. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5BSH2G9BH8

CAS Registry Number

825600-90-6

RxNorm Concept ID

1293254

Detailed Substance Profile

Preferred Name

LUCINACTANT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C172611

National Cancer Institute reference terminology for clinical and research data.

USAN ID

RR-136

Identifier assigned by the United States Adopted Names Council.

Substance Type

specifiedSubstanceG1

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lucinactant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LUCINACTANT

Common Names & Synonyms

KL-SURFACTANT

LUCINACTANT (DIPALMITOYLPHOSPHATIDYLCHOLINEPALMITIC ACIDSINAPULTIDE ACETATESODIUM PALMITOYLOLEOYLPHOSPATIDYLGLYCEROL)

LUCINACTANT [ORANGE BOOK]

LUCINACTANT [USAN]

LUCINACTANT [WHO-DD]

Brand / Trade Names

SURFAXIN

Systematic Nomenclature

A SURFACTANT FORMULATION COMPRISED OF SINAPULTIDE, COLFOSCERIL PALMITATE (DIPALMITOYLPHOSPHATIDYLCHOLINE (DPPC)), PALMITOYLOLEAYLPHOSPHATIDYL GLYCEROL, SODIUM SALT (POPG), AND PALMITIC ACID

SYS